145 related articles for article (PubMed ID: 11123013)
1. Penicillamine in the treatment of systemic sclerosis.
Clements PJ
Curr Rheumatol Rep; 1999 Oct; 1(1):38-42. PubMed ID: 11123013
[TBL] [Abstract][Full Text] [Related]
2. D-penicillamine is not an effective treatment in systemic sclerosis.
Furst DE; Clements PJ
Scand J Rheumatol; 2001; 30(4):189-91. PubMed ID: 11578010
[TBL] [Abstract][Full Text] [Related]
3. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
4. D-penicillamine in systemic sclerosis? Yes!
Medsger TA; Lucas M; Wildy KS; Baker C
Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
[TBL] [Abstract][Full Text] [Related]
5. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Clements PJ; Seibold JR; Furst DE; Mayes M; White B; Wigley F; Weisman MD; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Wong WK
Semin Arthritis Rheum; 2004 Feb; 33(4):249-63. PubMed ID: 14978663
[TBL] [Abstract][Full Text] [Related]
6. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
7. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
Clements PJ; Hurwitz EL; Wong WK; Seibold JR; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen VD; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Furst DE
Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
[TBL] [Abstract][Full Text] [Related]
8. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
[TBL] [Abstract][Full Text] [Related]
9. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
Strand V
Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222
[No Abstract] [Full Text] [Related]
10. Clinical trials for the treatment of systemic sclerosis/scleroderma.
Varga J; Ponor I
Curr Rheumatol Rep; 1999 Oct; 1(1):13-4. PubMed ID: 11123008
[No Abstract] [Full Text] [Related]
11. Progressive systemic sclerosis and penicillamine.
Rodnan GP
J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
[TBL] [Abstract][Full Text] [Related]
12. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.
Steen VD; Medsger TA; Rodnan GP
Ann Intern Med; 1982 Nov; 97(5):652-9. PubMed ID: 7137731
[TBL] [Abstract][Full Text] [Related]
13. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
Jimenez SA; Sigal SH
J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
[TBL] [Abstract][Full Text] [Related]
14. Penicillamine in systemic sclerosis: a reappraisal.
Sattar MA; Guindi RT; Sugathan TN
Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
[TBL] [Abstract][Full Text] [Related]
15. Penicillamine therapy in systemic sclerosis.
Jayson MI; Lovell C; Black CM; Wilson RS
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
[TBL] [Abstract][Full Text] [Related]
16. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment.
Pasquali Ronchetti I; Guerra D; Quaglino D; Vincenzi D; Manzini E; Canossi B; Manzini CU
Clin Exp Rheumatol; 1989; 7(4):373-83. PubMed ID: 2591110
[TBL] [Abstract][Full Text] [Related]
17. Nodular scleroderma in systemic sclerosis under D-penicillamine therapy.
Sasaki T; Denpo K; Ono H; Nakajima H
J Dermatol; 1992 Dec; 19(12):968-71. PubMed ID: 1293190
[TBL] [Abstract][Full Text] [Related]
18. [Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl)].
Wozel G; Julius U
Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):85-93. PubMed ID: 6179735
[TBL] [Abstract][Full Text] [Related]
19. [Current status of D-penicillamine therapy in chronic polyarthritis].
Franke M; Menning H; Ströbel G
Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
[TBL] [Abstract][Full Text] [Related]
20. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
Mayes MD; O'Donnell D; Rothfield NF; Csuka ME
Arthritis Rheum; 2004 Feb; 50(2):553-7. PubMed ID: 14872498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
